Internal Medicine, Medical Oncology · South Portland, ME
NPI
1407823081
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
265 Western Ave Ste 2
South Portland, ME, 04106
Phone (207) 661-0200
Groups this clinician bills Medicare through
Medicare paid, 2024
$11K
123 services
Medicare patients, 2024
45
Average age 70
Drug cost, 2024
$431K
96 prescriptions
Company payments, 2025
$40
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew H Kulke was code 99214 (office e&m - established), 55 times for 21 patients. In total Matthew H Kulke billed 123 services in 10 codes, and Medicare paid $11K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-11-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 55 | 21 | $78.30 | $4,306 |
| 99233 Hospital E&M - Subsequent | Facility | 49 | 18 | $97.98 | $4,801 |
By year: 2022 $25K for 286 services; 2023 $16K for 182 services; 2024 $11K for 123 services.
Medicare prescription drug claims, 2024
In 2024, the drug Matthew H Kulke prescribed most often to Medicare patients was Xermelo (Telotristat Etiprate), with 23 prescriptions and refills. In total Matthew H Kulke wrote 96 Medicare prescriptions that cost $431K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Xermelo Telotristat Etiprate | 23 | 23 | Under 11 | $218K |
| Loperamide Loperamide Hcl | 12 | 14 | Under 11 | $242 |
Brand drugs: 47 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Matthew H Kulke $40 ($40 in general payments such as food, travel and fees) from 3 companies. The largest payer was Alexion Pharmaceuticals, Inc. with $40.
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. AZN | 1 | $40 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.